Board Meeting22 May 2026, 05:02 pm
Torrent Pharma: Board Approves FY26 Results, ₹9 Final Dividend
AI Summary
Torrent Pharmaceuticals Ltd's board approved audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹9 per equity share. The board also approved seeking shareholder approval for issuance of equity shares/convertible bonds/debentures via QIP or other modes up to ₹5,000 crores. The final dividend, if declared, will be paid around June 25, 2026; record date is May 29, 2026.
Key Highlights
- Audited financial results (standalone and consolidated) for FY26 approved with unmodified audit opinion.
- Final dividend of ₹9 (180%) per equity share recommended; record date is May 29, 2026.
- Approval sought for issuance of equity shares/convertible bonds/debentures up to ₹5,000 crores via QIP or other modes.
- Board meeting commenced at 2:00 pm and concluded at 4:00 pm.
- Interim dividend of ₹29 (580%) per equity share was previously paid.
Price Impact
More from TORNTPHARM